Preferred Global Health

Preferred Global Health

About Us

Preferred Global Health (PGH) is a global patient organization providing diagnosis, treatment plan development, and treatment from world leading experts at the top 1% ranked hospitals in the USA, and personal care management ensuring full process quality for treatment and patient care.

Based in Boston, Massachusetts, PGH has more than 20 years’ experience in patient advocacy and in supporting patients and their families in their path to recovery. The Medical Board consists of experts with distinguished careers who are at the forefront of hospital departments and multidisciplinary research.

PGH is committed to ensuring the best possible outcome for patients facing diagnosis of critical illness, such as stroke, heart disease and cancer.

Bridging the gap in healthcare delivery

Bridging the gap in healthcare delivery

~50% of the population will die
from cancer or cardiovascular
diseases 1

Large global differences in
medical practice and
protocols

Huge gaps in global medical practice and patient outcomes

Approximately 20 - 25%
of all patients experience
preventable medical errors 3

Statistically ~30%
better outcome at top 1%
U.S. hospitals 2

VOLUME
Difference in experience level between world-leading experts and local practitioners
R&D
Large R&D funding at leading institutions allows them to stay ahead with cutting-edge protocols and technology
MAIN CAUSES OF PREVENTABLE MEDICAL ERRORS
  • Wrong or Inferior treatment plan
  • Communication breakdown between multiple specialists involved
  • Inexperienced medical teams
  • Cost minimization focus, not best outcome
  • Best course of treatment unavailable on a local or national level
  • Lack of orchestration or coordination
  • Lack of informed patient participation in treatment decision-making

Who do you turn to when you have been diagnosed with cancer or critical heart problems?

PGH Diagnosed
PGH Services

PGH Diagnosed

Diagnostic Verification and Treatment Plan (DVTP) by Harvard level experts – the best second opinion in the world

PGH Diagnosed

Doctor-to-Doctor Dialogue (DDD) – the best minds collaborating on your case

PGH Diagnosed

U.S. Care Management during Treatment at a top 1% ranked hospital in the USA, if you choose

PGH Diagnosed

Dedicated Personal Care Manager ensuring quality and managing process

PGH Diagnosed

Covers cancer and cardiovascular disease – accounting for ~50% of deaths

Path to best outcome

PGH

Option 1: Local treatment is fully handled by local medical personnel and not assisted by PGH.
Option 2: Treatment handled by local medical personnel under local cover, but Harvard-level experts provide professional advice on case and treatment.

Personal Care Manager ensuring full process quality for the patient treatment

PGH
PGH
Personal Care Management

All PGH members diagnosed with a covered disease are assigned a personal care manager to advocate on their behalf.

Key characteristics and responsibilities include:

Medically skilled project manager with end-to-end responsibility for entire process and patient journey
Secure quality in every step of the way
Enhance doctor-patient communication
Reduce the probability of treatment errors and unnecessary treatment
Orchestrate services
Help the patient in making informed decisions
End-to-end administrative handling of U.S. treatment, including flights, accommodation, coordination, payments, etc
Ensure that all questions are answered, concerns eliminated wherever possible, all risks properly handled and that patient-specific health issues are handled accurately

Services & treatment from the top 1% of U.S. hospitals orchestrated by world leading experts

Medical Board
PGH

Stephen E. Sallan, MD, PGH Medical Board Chairman

Chief of Staff Emeritus and Chairman of the Medical Staff Executive Committee at Dana-Farber Cancer Institute (DFCI) since 1995, Dr. Stephen E. Sallan is a renowned pediatric oncologist and Professor at Harvard Medical School. His clinical research focuses on the genetic heterogeneity and treatment of the most common malignancy of childhood, acute lymphoblastic leukemia, to understand the reasons for disease recurrence and drug resistance.

Dr. Sallan has received the Distinguished Alumni Award from the Wayne State University School of Medicine. He completed residencies at the Children’s Hospital of Philadelphia and in London, UK, and fellowship at Children’s Hospital Boston and DFCI. Institute. Dr Sallan has been honored as the James Carreras Prize for International Pediatrician of the Year and the Boston Red Sox Biomedical All Star Award.


PGH

Lawrence Nathan Shulman, MD

Dr. Shulman is Deputy Director for Clinical Services, and Director, Center for Global Cancer Medicine in the Abramson Cancer Center at University of Pennsylvania. Since 2017 he was elected as Chair of the Commission on Cancer of the American College of Surgeons. He was chief of staff at the Dana Farber Cancer Institute from 2012 to 2015, at which time he also accepted leadership roles as the Institute’s director of regional strategy development and network of cancer centers. He has worked with Partners in Health to bring quality cancer programs to Rwanda and Haiti. Dr. Shulman has also worked with WHO to update the Essential Medicines List of Cancer and serves on the International Affairs Committee of the American Society of Clinical Oncology. He affiliated with Harvard Medical School’s Department of Global Health and Social Medicine in 2013.

Dr. Shulman is a practicing medical oncologist with specialization in breast cancer and is involved in clinical research. He received his bachelor's degree from Syracuse University and medical degree from Harvard Medical School.


PGH

Gilbert H. Mudge, MD

Dr. Gilbert H. Mudge Jr is President and CEO of Partners Medical International since 2011. He is a global health expert, a Professor of Medicine at Harvard Medical School, and a world-renowned cardiologist at Brigham and Women’s Hospital (BWH) specializing in heart failure, cardiac transplantation and mechanical hearts. His international career of over two decades includes developing clinical sub-specialty programs, quality initiatives and educational programs throughout Asia, Europe and the Middle East. Dr Mudge has served in various leadership roles at BWH and Partners.

He was asked to start the first heart transplant program in New England in 1983 and has followed hundreds of such patients to date. Dr. Mudge has been named one of the Best Doctors in Boston by Boston Magazine for five years and has been honored with the Partners in Excellence Award five times. Dr Mudge graduated from Columbia University and completed his internal medicine training at Presbyterian Hospital in New York.